Dividend-adjusted total return · S&P 500 uses VOO · Oct 28, 2021 – Nov 5, 2026IDNAS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −6.2% | +1.3% | +19.1% | +58.8% | +70.0% | +136.6% | −13.5% | +78.7% |
| Peer average | −3.4% | +4.6% | +3.5% | +19.7% | +29.0% | +75.3% | +27.3% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $335M
- Expense ratio
- 0.47%
- Distribution yield
- 0.7%
- NAV
- $41.36
- Volume
- 293K
- Avg. volume 30D
- 188K
- High today
- $43.81
- Low today
- $41.21
- Previous close
- $44.15
- 52-week high
- $44.15
- 52-week low
- $24.29
- Our risk indicator
- 4/5
IDNA in One Breath
IDNA Among Health Care ETFs
YTDEnd-of-day Nov 6, 2026 · 33 Health care ETFs by YTD
$10,000 in IDNA
5Y$10,000 in IDNA became
$8,654
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
IDNA’s Top Holdings
TodayMRNAModerna14.6%GMAB.CO5.8%TWST5.5%REGN3.9%BAYN.DE3.9%EXEL3.7%4502.T3.6%RVMD3.6%CAI3.4%MRK3.3%VRTX3.3%INCY3.2%ROP.SW3.1%IOVA2.8%IBRX2.8%SAN.PA2.8%BNTX2.8%GSK.L2.6%IPN.PA2.6%ABCL2.4%IDYA2.3%28 more
MRNAModerna14.6%GMAB.CO5.8%TWST5.5%REGN3.9%BAYN.DE3.9%EXEL3.7%4502.T3.6%RVMD3.6%CAI3.4%MRK3.3%VRTX3.3%38 more
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - Specialty
iShares IDNA · 50 holdings · tile size = share of the fund · as of Nov 5, 2026
What IDNA Holds
TodayBiotechnology72.0%
MRNA 14.6 · GMAB.CO 5.8 · TWST 5.5 · REGN 3.9 · EXEL 3.7 · RVMD 3.6 · CAI 3.4
Drug Manufacturers - General17.2%
BAYN.DE 3.9 · MRK 3.3 · ROP.SW 3.1 · SAN.PA 2.8 · GSK.L 2.6 · 4528.T 1.4
Drug Manufacturers - Specialty & Generic7.3%
4502.T 3.6 · IPN.PA 2.6 · 6887.HK · ALVO
Medical - Diagnostics & Research0.8%
PSNL
Medical - Devices0.6%
PACB
Other holdings2.0%
VLA.PA · CTMX · DSGN · 2696.HK · OCGN · 174900.KQ
iShares IDNA · share of the fund by industry · as of Nov 5, 2026
Moderna’s Share of IDNA
Today14.6%
$146 of every $1,000 in IDNA is Moderna
Moderna held by IDNA
$48.8M
iShares IDNA · each square = $10 of $1,000 · as of Nov 5, 2026
IDNA’s Share of Health Care ETFs
Today0.3%
of the $112B in 39 Health care ETFs
$335M0.3%
$50.9B45.4%
$19.1B17.0%
$41.8B37.2%
Health care ETF AUM · Nov 6, 2026
IDNA Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 6, 2026
Inside IDNA
50 holdings · as of Nov 5, 2026IDNA
iShares Genomics Immunology and Healthcare ETF
TodayBiotechnology72.0%MRNAModerna14.6%GMAB.CO5.8%TWST5.5%REGN3.9%EXEL3.7%RVMD3.6%CAI3.4%VRTX3.3%INCY3.2%IOVA2.8%IBRX2.8%BNTX2.8%ABCL2.4%IDYA15 more holdings11.9% of the fundDrug Manufacturers - General17.2%BAYN.DE3.9%MRK3.3%ROP.SW3.1%SAN.PAGSK.L2.6%Drug Manufacturers - Specialty7.3%4502.T3.6%IPN.PA2.6%ALVOPSNLPACBOther2.0%
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 14.57% |
| 2 | GMAB.CO | Genmab | 5.84% |
| 3 | TWST | Twist Bioscience | 5.51% |
| 4 | REGN | Regeneron Pharmaceuticals | 3.92% |
| 5 | BAYN.DE | Bayer AG | 3.90% |
| 6 | EXEL | Exelixis | 3.69% |
| 7 | 4502.T | Takeda Pharmaceutical | 3.62% |
| 8 | RVMD | Revolution Medicines | 3.58% |
| 9 | CAI | Caris Life Sciences | 3.42% |
| 10 | MRK | Merck & | 3.33% |
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - SpecialtyMedical - DiagnosticsMedical - DevicesOther
iShares IDNA · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 79.9%
All IDNA Holdings
62 holdings · as of Nov 5, 2026IDNA
IDNA’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 14.57% | $1,457.50 | 200K | $51.8M |
| 2 | GMAB.COGenmab | Healthcare | 5.84% | $584.09 | 39K | $20.7M |
| 3 | TWSTTwist Bioscience | Healthcare | 5.51% | $551.21 | 137K | $19.6M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 3.92% | $391.92 | 15K | $13.9M |
| 5 | BAYN.DEBayer AG | Healthcare | 3.90% | $390.39 | 227K | $13.9M |
| 6 | EXELExelixis | Healthcare | 3.69% | $369.23 | 180K | $13.1M |
| 7 | 4502.TTakeda Pharmaceutical | Healthcare | 3.62% | $361.51 | 309K | $12.8M |
| 8 | RVMDRevolution Medicines | Healthcare | 3.58% | $358.13 | 64K | $12.7M |
| 9 | CAICaris Life Sciences | Healthcare | 3.42% | $341.83 | 365K | $12.1M |
| 10 | MRKMerck | Healthcare | 3.33% | $333.26 | 79K | $11.8M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 3.29% | $328.90 | 21K | $11.7M |
| 12 | INCYIncyte | Healthcare | 3.21% | $320.87 | 93K | $11.4M |
| 13 | ROP.SWRoche PS PAR AG | Healthcare | 3.15% | $314.84 | 23K | $11.2M |
| 14 | IOVAIovance Biotherapeutics | Healthcare | 2.84% | $283.59 | 1.2M | $10.1M |
| 15 | IBRXImmunitybio | Healthcare | 2.82% | $282.16 | 1.1M | $10.0M |
iShares IDNA · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
IDNA
iShares Genomics Immunology and Healthcare ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put IDNA head to head with XLV →XLV vs IDNA
YTDYear to date
IDNA wins+37.9 pts
Past year
IDNA wins+40.4 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV152.0× more
2–2level
SPDR XLV and iShares IDNA · year-to-date · as of Nov 6, 2026 · AUM not scored
IDNA vs VOO
YTDIDNA · iShares Genomics Immunology and Healthcare
+58.8%
VOO · S&P 500
+8.4%
Gap
50.4 pts
iShares IDNA and Vanguard VOO · YTD total return · as of Nov 6, 2026
IDNA vs Its Peer Average
YTDIDNAAvsBPeer average
1D−6.2%−3.4%
1M+1.3%+4.6%
3M+19.1%+3.5%
YTD+58.8%+19.7%
1Y+70.0%+29.0%
3Y+136.6%+75.3%
5Y−13.5%+27.3%
4–3IDNA wins
38 Health care peers · each row scaled to its leader
The Details
IDNA
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y30.57%
Deepest drop · 1Y−10.6%
Lowest point · 5Y−63.4%
52-week range
$41.42
$24.29−6.2% from the high$44.15
iShares IDNA · past-year price moves · as of Nov 6, 2026
IDNA
Fund Facts
Today2019launched Jun 11
Tracks[…]
Exchange · CUSIPAMEX · 46435U192
StructureETF
Leverage1x
Cost on $10,000$47 a year
Go deeper
iShares IDNA · fund facts · as of Nov 6, 2026
IDNA
Payouts by Year
8Y$0.13per share, Jun 2026
Distribution yield0.7%
PaidTwice a year
Latest ex-date · paidJun 15 · Jun 18, 2026
12 payouts added up$1.46 a share
iShares IDNA · distributions by ex-date · 2019–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$41.36
Premium / discount[…]
Median spread · 30D[…]
Volume today293K
Average volume · 30D188K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.47%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$47.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.13 |
| Dec 16, 2025 | Dec 19, 2025 | $0.16 |
| Jun 16, 2025 | Jun 20, 2025 | $0.15 |
| Dec 17, 2024 | Dec 20, 2024 | $0.11 |
| Jun 11, 2024 | Jun 17, 2024 | $0.11 |
| Dec 20, 2023 | Dec 27, 2023 | $0.17 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0708 |
| Jun 9, 2022 | Jun 15, 2022 | $0.14 |
| Dec 13, 2021 | Dec 17, 2021 | $0.26 |
| Jun 10, 2021 | Jun 16, 2021 | $0.0521 |
| Dec 14, 2020 | Dec 18, 2020 | $0.0362 |
| Jun 15, 2020 | Jun 19, 2020 | $0.0837 |
Issuer contentFrom iSharesHear the strategy from the people behind IDNA.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →